Economic and Clinical Burden of Acute Myeloid Leukemia Episodes of Care in the United States: A Retrospective Analysis of a Commercial Payer Database

BACKGROUND: In the United States, the incidence of acute myeloid leukemia (AML) has steadily increased over the last decade; in 2019, it was estimated that AML would affect 21,450 new patients and lead to 10,920 deaths. Detailed real-world cost estimates and comparisons of key AML treatment episodes...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandya, Bhavik J., Chen, Chi-Chang, Medeiros, Bruno C., McGuiness, Catherine B., Wilson, Samuel D., Walsh, Elise Horvath, Wade, Rolin L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391266/
https://www.ncbi.nlm.nih.gov/pubmed/32281456
http://dx.doi.org/10.18553/jmcp.2020.19220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391266/
https://www.ncbi.nlm.nih.gov/pubmed/32281456
http://dx.doi.org/10.18553/jmcp.2020.19220

Ejemplares similares